Vandria closes Series A round at CHF28.3m

Adcendo broadens ADC pipeline in US$1bn biobucks deal

Emfret presents novel anticoagulant

BioNTech: ADC study continues with conditions

Evotec axes 400 jobs worldwide

Nitrogenases also can fix CO2

Sphingotec secures Series C financing

New antibiotic breaks resistance

Roche inks US$2bn biobucks deal with Sangamo